Investors in Catalent, Inc. CTLT need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $20 Put had some of the highest implied volatility...
Monday Markets are closed for Labour Day Tuesday U.S. Economic Lookahead ...
Catalent, Inc. CTLT reported fourth-quarter fiscal 2024 adjusted earnings per share (EPS) of 65 cents, which was significantly up from the year-ago period’s EPS of 2 cents. The figure surpassed the Zacks...
/Catalent%20Inc_%20HQ%20in%20New%20Jersey-by%20JHVEPhoto%20via%20Shutterstock.jpg)
While Catalent has outperformed the broader market over the past year, analysts are cautious about the stock’s potential.
A small telemedicine company just entered the weight loss race.
/Catalent%20Inc_%20on%20phone%20and%20website-by%20T_Schneider%20via%20Shutterstock.jpg)
Catalent will unveil its Q4 earnings in September, and analysts project a triple-digit bottom-line growth.
The recent announcement that China approved Novo Nordisk's Wegovy is huge. Here's why: In a national survey conducted during 2015-2019 by China’s National Health Commission, more than half of the adult...
This year, the financial landscape has been shaped by high interest rates and tenacious inflation, a combination of scenarios that have significantly influenced various sectors of the economy. For investors,...
Plowing $9 billion into a manufacturing facility could help a successful tirzepatide launch reach new heights.